Back to search

Article

Antimullerian Hormone Levels by Phenotypes in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

2025-01-27

Abstract excerpt

<h4>Structured abstract</h4> <h4>Objective</h4> This study aims to evaluate antimüllerian hormone (AMH) levels across Polycystic Ovary Syndrome (PCOS) phenotypes (A, B, C, D) based on the Rotterdam diagnostic criteria. <h4>Data Sources</h4> A systematic review and meta-analysis were conducted following PRISMA guidelines. PubMed, Embase, ScienceDirect, and Web of Science were searched for studies published between...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7133a13b-ad82-54c3-8d77-1868cc33e993
DOI
10.1101/2025.01.25.25321110
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antimullerian Hormone Levels by Phenotypes in Polycystic Ovary Syndrome: A Systematic Review and Meta-AnalysisDOI 10.1101/2025.01.25.25321110
The Diagnostic Performance of Antimullerian Hormone for Polycystic Ovarian Syndrome and Polycystic Ovarian MorphologySemantic proximity
Demographic, clinical characteristics, polycystic ovarian syndrome phenotypes and predictors of anti-mullerian hormone among women with PCOS at a Fertility Center in Ghana: A 5-year retrospective studySemantic proximity
Polycystic ovary syndrome v.2023: Simplified diagnostic criteria for an East Asian phenotype.Semantic proximity
The diagnostic performance of antimullerian hormone for polycystic ovarian syndrome and polycystic ovarian morphology.Semantic proximity
When one size does not fit all: Reconsidering PCOS etiology, diagnosis, clinical subgroups, and subgroup-specific treatmentsSemantic proximity
Comparison of clinical and hormonal characteristics among four phenotypes of polycystic ovary syndrome based on the Rotterdam criteria.Semantic proximity
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes.Semantic proximity
Tailoring treatment for PCOS phenotypes.Semantic proximity
AMH levels and diagnosis in PCOS phenotype D.Semantic proximity
Serum Anti-Mullerian Hormone (AMH) Levels Among Different PCOS Phenotypes and Its Correlation with Clinical, Endocrine, and Metabolic Markers of PCOS.Semantic proximity
Association of antimüllerian hormone with polycystic ovarian syndrome phenotypes and pregnancy outcomes of in vitro fertilization cycles with fresh embryo transfer.Semantic proximity
Metabolic Syndrome Rather Than Other Phenotypes in PCOS as a Predictive Indicator for Clinical Outcomes in IVF: Comprehensive Phenotypic Assessment across All PCOS ClassificationsSemantic proximity
Select a neighboring publication to make it the new centre.